CLINICAL OBSERVATION OF THE USE OF ORAL VINORELBINE IN THE TREATMENT OF DISSEMINATED ESTROGEN-RECEPTORPOSITIVE, HER2-NEGATIVE BREAST CANCER. Wor.Bul.Soc.Sci. [Internet]. 2022 Feb. 10 [cited 2026 Mar. 31];7:1-4. Available from: https://scholarexpress.net/index.php/wbss/article/view/514